We are live on ! Find out more
HWAM

Hennion & Walsh Asset Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 41.95%
This Fund
S&P 500
This Quarter Est. Return
+1.92%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
AUM
$1.95B
AUM Growth
+$76.2M
Cap. Flow
+$63.5M
Cap. Flow %
3.26%
Top 10 Hldgs %
17.61%
Holding
910
New
70
Increased
404
Reduced
353
Closed
72
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SJM icon
401
J.M. Smucker
SJM
$12.7B
$1.11M 0.06%
10,172
+126
+1% +$14.3K
ETO
402
Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund
ETO
$525M
$1.11M 0.06%
43,357
+1,023
+2% +$25.4K
BRX icon
403
Brixmor Property Group
BRX
$9.14B
$1.09M 0.06%
47,222
-3,356
-7% -$74.2K
CPRT icon
404
Copart
CPRT
$27.1B
$1.08M 0.06%
19,970
+2,453
+14% +$134K
COGT icon
405
Cogent Biosciences
COGT
$6.68B
$1.08M 0.06%
+127,712
New +$969K
GERN icon
406
Geron
GERN
$988M
$1.08M 0.06%
+253,857
New +$990K
CPB icon
407
Campbell Soup
CPB
$6.68B
$1.06M 0.05%
23,541
-1,689
-7% -$75.3K
HCM icon
408
HUTCHMED
HCM
$2.18B
$1.06M 0.05%
61,887
+4,877
+9% +$90K
NIM icon
409
Nuveen Select Maturities Municipal Fund
NIM
$116M
$1.06M 0.05%
117,041
-31,886
-21% -$284K
BDJ icon
410
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.75B
$1.05M 0.05%
128,789
+11,446
+10% +$93.1K
MDLZ icon
411
Mondelez International
MDLZ
$77.9B
$1.05M 0.05%
15,987
+823
+5% +$56.5K
UTHR icon
412
United Therapeutics
UTHR
$22.6B
$1.04M 0.05%
3,263
-28
-0.9% -$7.41K
CVS icon
413
CVS Health
CVS
$120B
$1.04M 0.05%
17,583
-8,211
-32% -$514K
AMT icon
414
American Tower
AMT
$79.2B
$1.03M 0.05%
5,304
-2,088
-28% -$390K
FN icon
415
Fabrinet
FN
$19B
$1.03M 0.05%
+4,190
New +$889K
DHF
416
BNY Mellon High Yield Strategies Fund
DHF
$173M
$1.01M 0.05%
421,068
+92,837
+28% +$220K
PCRX icon
417
Pacira BioSciences
PCRX
$969M
$1.01M 0.05%
+35,450
New +$1.01M
AMD icon
418
Advanced Micro Devices
AMD
$766B
$1.01M 0.05%
6,251
+4,788
+327% +$770K
LYB icon
419
LyondellBasell Industries
LYB
$20.6B
$1.01M 0.05%
10,534
+3,412
+48% +$339K
IDA icon
420
Idacorp
IDA
$8.06B
$1M 0.05%
10,751
-267
-2% -$25.1K
BBVA icon
421
Banco Bilbao Vizcaya Argentaria
BBVA
$158B
$1M 0.05%
99,817
+1,376
+1% +$14.8K
BBIO icon
422
BridgeBio Pharma
BBIO
$16.7B
$990K 0.05%
39,099
-104,995
-73% -$2.87M
J icon
423
Jacobs Solutions
J
$17.3B
$989K 0.05%
8,561
+3,469
+68% +$407K
OKE icon
424
Oneok
OKE
$57.1B
$984K 0.05%
12,071
-4,856
-29% -$388K
BXMX
425
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
$982K 0.05%
72,741
-44,006
-38% -$575K

Similar funds

Hennion & Walsh Asset Management's Q2 2024 Portfolio in Review

As of Q2 2024, Hennion & Walsh Asset Management held 910 positions worth $1.95B, up 4.1% from $1.87B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Hennion & Walsh Asset Management deployed $63.5M of net new capital in Q2 2024, opening 70 new positions and adding to 404 existing holdings. Its largest new stake was ProShares S&P 500 High Income ETF: 844,883 shares worth $36.8M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 12% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was DWS Municipal Income Trust, an estimated $3.23M trimmed.

  • Hennion & Walsh Asset Management's largest Q2 2024 buy was ProShares S&P 500 High Income ETF: 844,883 shares worth $36.8M.
  • Hennion & Walsh Asset Management added most to Goldman Sachs ActiveBeta International Equity ETF in Q2 2024, an estimated $10.5M increase.
  • Hennion & Walsh Asset Management's biggest Q2 2024 reduction was DWS Municipal Income Trust, cutting an estimated $3.23M.
  • Hennion & Walsh Asset Management fully exited JPMorgan Equity Premium Income ETF in Q2 2024, selling an estimated $35.6M.
  • Hennion & Walsh Asset Management's ten largest holdings make up 18% of its $1.95B portfolio in Q2 2024.
  • Hennion & Walsh Asset Management opened 70 new positions and closed 72 in Q2 2024.
  • Hennion & Walsh Asset Management's portfolio value rose 4.1% quarter-over-quarter to $1.95B.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2024, filed 19 Jul 2024.